SG Americas Securities LLC Sells 49,785 Shares of Alignment Healthcare, Inc. $ALHC

SG Americas Securities LLC decreased its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 82.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,605 shares of the company’s stock after selling 49,785 shares during the period. SG Americas Securities LLC’s holdings in Alignment Healthcare were worth $187,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. boosted its position in shares of Alignment Healthcare by 10.9% during the fourth quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock valued at $305,983,000 after purchasing an additional 1,524,218 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of Alignment Healthcare by 26.9% during the fourth quarter. Wellington Management Group LLP now owns 14,070,893 shares of the company’s stock valued at $277,900,000 after purchasing an additional 2,981,166 shares in the last quarter. T. Rowe Price Investment Management Inc. boosted its position in shares of Alignment Healthcare by 0.6% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock worth $249,715,000 after purchasing an additional 79,268 shares in the last quarter. Invesco Ltd. raised its stake in Alignment Healthcare by 38.9% during the fourth quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock valued at $122,501,000 after buying an additional 1,735,962 shares during the last quarter. Finally, 8 Knots Management LLC grew its stake in shares of Alignment Healthcare by 6.4% in the second quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock worth $70,222,000 after acquiring an additional 300,409 shares during the last quarter. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, insider Hyong Kim sold 35,951 shares of the stock in a transaction on Friday, June 12th. The shares were sold at an average price of $19.86, for a total transaction of $713,986.86. Following the completion of the transaction, the insider owned 331,750 shares in the company, valued at $6,588,555. This trade represents a 9.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $19.55, for a total transaction of $586,500.00. Following the transaction, the president owned 947,313 shares of the company’s stock, valued at $18,519,969.15. This trade represents a 3.07% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 854,250 shares of company stock valued at $16,396,606 over the last quarter. 5.20% of the stock is currently owned by insiders.

Alignment Healthcare Price Performance

ALHC traded down $1.20 during trading on Friday, reaching $19.83. 3,946,573 shares of the company traded hands, compared to its average volume of 5,119,038. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.58 and a current ratio of 1.58. The firm has a fifty day simple moving average of $19.07 and a 200 day simple moving average of $19.79. Alignment Healthcare, Inc. has a 12-month low of $11.63 and a 12-month high of $25.12. The company has a market cap of $4.10 billion, a P/E ratio of 220.33, a PEG ratio of 2.68 and a beta of 1.05.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, April 30th. The company reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.04. The company had revenue of $1.24 billion during the quarter, compared to analyst estimates of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The firm’s revenue was up 33.3% on a year-over-year basis. During the same period in the prior year, the company earned ($0.05) earnings per share. On average, equities analysts forecast that Alignment Healthcare, Inc. will post 0.2 EPS for the current year.

More Alignment Healthcare News

Here are the key news stories impacting Alignment Healthcare this week:

• Negative Sentiment: Multiple plaintiff law firms, including Howard G. Smith, Kaplan Fox, Frank R. Cruz, Kirby McInerney, Hagens Berman, and Block & Leviton, announced investigations into possible securities-law violations and whistleblower allegations involving Alignment Healthcare. Article: Alignment Healthcare, Inc. (ALHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
• Negative Sentiment: Reports that a former executive alleged accounting irregularities and inflated financial results are likely raising investor concerns about the quality of ALHC’s reported numbers and future legal risk. Article: ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation
• Neutral Sentiment: Alignment Healthcare said it will report second-quarter 2026 results on July 30, an event that could become a near-term stock catalyst if investors look for clarity on the allegations and business performance. Article: Alignment Healthcare to Announce Second Quarter 2026 Financial Results and Host Conference Call Thursday, July 30, 2026
• Neutral Sentiment: A short-interest update showed zero reported short interest, offering little incremental trading signal for ALHC. Article: Alignment Healthcare, Inc. (ALHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the stock. Weiss Ratings upgraded shares of Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Thursday, May 7th. UBS Group reissued a “neutral” rating on shares of Alignment Healthcare in a research report on Wednesday. Raymond James Financial set a $22.00 price objective on shares of Alignment Healthcare in a report on Thursday, May 7th. Zacks Research cut Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Finally, KeyCorp reissued an “overweight” rating on shares of Alignment Healthcare in a research report on Wednesday, June 10th. Six analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, Alignment Healthcare has a consensus rating of “Moderate Buy” and an average target price of $24.30.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.